Audentes Therapeutics, Inc. Shareholders' Equity
Audentes Therapeutics, Inc. had Shareholders' Equity of $383.46 million as of 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2019-11-07
- 2019-09-30: Stockholders' Equity Attributable to Parent $383.46M.
- 2019-06-30: Stockholders' Equity Attributable to Parent $419.70M.
- 2019-03-31: Stockholders' Equity Attributable to Parent $402.00M.
- 2018-12-31: Stockholders' Equity Attributable to Parent $442.75M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2019-09-30 | $383.46M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $419.70M 10-Q · filed 2019-11-07 |
| 2019-03-31 | $402.00M 10-Q · filed 2019-11-07 |
| 2018-12-31 | $442.75M 10-Q · filed 2019-11-07 |
| 2018-09-30 | $310.56M 10-Q · filed 2019-11-07 |
| 2018-06-30 | $340.96M 10-Q · filed 2019-11-07 |
| 2018-03-31 | $352.44M 10-Q · filed 2019-11-07 |
| 2017-12-31 | $156.60M 10-Q · filed 2019-11-07 |
| 2017-09-30 | $175.32M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $162.05M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $102.53M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $119.37M 10-K · filed 2019-03-01 |
| 2016-09-30 | $138.36M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $77.88M 10-Q · filed 2016-09-01 |
| 2015-12-31 | $101.69M 10-K · filed 2019-03-01 |
| 2014-12-31 | $59.86M 10-K · filed 2018-03-09 |
| 2013-12-31 | $12.91M 10-K · filed 2017-03-13 |